At Molekule, we value the rigour of the scientific process. It allows us to innovate and deliver the best-performing air purification technology to your home. The Molekule technology (PECO) was originally developed over 20 years at the university level and then brought from the laboratory into the home. It was only through experimentation and the scientific method that we could confidently claim that the Molekule air purifier destroys pollutants and produces truly clean air. Polluted air has become a health epidemic that was largely unknown until recently. This was important to address because nothing touches our lives more than the air we breathe.
That is why we are sharing our first pilot study performed with real people who used the Molekule air purifier in their homes. Published in the journal Allergy & Rhinology, the study focused on 46 participants with eye and nasal symptoms consistent with allergy and asthma sufferers. The participants were asked to use Molekule in their home daily for four weeks and report weekly on their symptoms.
What is the significance of a “pilot study?”
A pilot study is the fundamental first step in the research process when exploring a new intervention. It is the small-scale version that if successful, determines whether your approach makes sense to be studied on a larger scale, where it can hold even more scientific weight. It is essentially a rite of passage that when crossed, can tell you whether the results are worth considering and promises more robust scientific data to follow. This study was the first pilot research study of the impact of the Molekule technology with real people.
Even at a small-scale size of 46 participants, the Molekule pilot study was performed at a high level of scientific rigor, enough to be accepted and published in a peer-reviewed journal.
Why is peer-reviewed important?
A peer-reviewed work must meet rigorous scientific standards, meaning the researchers’ work was vetted by the scientific community as being of academic quality before it was published. Importantly, the study focused on real people reporting the impact of Molekule use on their symptoms, as opposed to testing the capability of the technology by simply reporting chemical measurements from lab instruments.
As a pilot study, this report is the first of many other studies to come that will test the impacts of Molekule air purifiers, and specifically PECO technology, on an even larger scale.
After it was approved by an independent institutional review board for research studies, the study ran from March 2015 to April 2017 with 46 adults interested in testing Molekule’s ability to reduce their asthma and allergy symptoms. After seeing an invitation on social media, each subject expressed interest in testing Molekule’s Home One unit for one month. All reported some degree of nasal or eye allergy symptoms, and some also reported asthma symptoms. A small number of participants specifically agreed to test the unit to see if it helped with their sleep quality as related to their eye and nasal symptoms.
Researchers asked participants to run the air purifier for at least 12 hours a day and preferably at night with the unit close to their bed. During the study, participants were asked to continue their normal medications for allergic symptoms, asthma, and any other general medical condition, as well as to continue their usual routine for managing allergies and asthma. Participants scored their eye symptoms, nasal symptoms, asthma symptoms, and sleep quality on a weekly basis during the study.
Researchers then analyzed all of the data collected and drew conclusions. They also cited the limitations of the study and suggested further research based on the findings. We invite you to dig into these real results and decide for yourself.
SagePub – Effect of a Novel… on Scribd